Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population

Performance of three automated commercial serological IgG-based assays was investigated for assessing SARS-CoV-2 “ever” (past or current) infection in a population-based sample in a high exposure setting. PCR and serological testing was performed on 394 individuals. SARS-CoV-2-IgG seroprevalence was...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasrallah, Gheyath K., Dargham, Soha R., Shurrab, Farah, Al-Sadeq, Duaa W., Al-Jighefee, Hadeel, Chemaitelly, Hiam, Al Kanaani, Zaina, Al Khal, Abdullatif, Al Kuwari, Einas, Coyle, Peter, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Rahim, Hanan F. Abdul, Yassine, Hadi M., Al Kuwari, Mohamed G., Qotba, Hamda, Al Romaihi, Hamad Eid, Tang, Patrick, Bertollini, Roberto, Al-Thani, Mohamed H., Althani, Asmaa A., Abu-Raddad, Laith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178338/
https://www.ncbi.nlm.nih.gov/pubmed/34088944
http://dx.doi.org/10.1038/s41598-021-91235-x

Ejemplares similares

Ejemplares similares